UBS AM’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37B | Buy |
3,067,473
+507,997
| +20% | +$226M | 0.28% | 68 |
|
|
2025
Q1 | $1.24B | Buy |
2,559,476
+230,257
| +10% | +$112M | 0.32% | 61 |
|
|
2024
Q4 | $938M | Sell |
2,329,219
-112,249
| -5% | -$45.2M | 0.22% | 82 |
|
|
2024
Q3 | $1.14B | Sell |
2,441,468
-142,859
| -6% | -$66.4M | 0.29% | 64 |
|
|
2024
Q2 | $1.21B | Buy |
2,584,327
+138,275
| +6% | +$64.8M | 0.35% | 49 |
|
|
2024
Q1 | $1.02B | Sell |
2,446,052
-153,852
| -6% | -$64.3M | 0.36% | 48 |
|
|
2023
Q4 | $1.06B | Sell |
2,599,904
-173,895
| -6% | -$70.8M | 0.42% | 39 |
|
|
2023
Q3 | $965M | Sell |
2,773,799
-37,932
| -1% | -$13.2M | 0.43% | 38 |
|
|
2023
Q2 | $886M | Hold |
2,811,731
| – | – | 0.43% | 39 |
|
|
2023
Q1 | $886M | Sell |
2,811,731
-117,685
| -4% | -$37.1M | 0.43% | 39 |
|
|
2022
Q4 | $846M | Sell |
2,929,416
-229,276
| -7% | -$66.2M | 0.44% | 39 |
|
|
2022
Q3 | $915M | Buy |
3,158,692
+36,378
| +1% | +$10.5M | 0.51% | 32 |
|
|
2022
Q2 | $880M | Sell |
3,122,314
-17,023
| -0.5% | -$4.8M | 0.46% | 35 |
|
|
2022
Q1 | $819M | Sell |
3,139,337
-374,894
| -11% | -$97.8M | 0.35% | 53 |
|
|
2021
Q4 | $772M | Buy |
3,514,231
+755,378
| +27% | +$166M | 0.3% | 65 |
|
|
2021
Q3 | $500M | Buy |
2,758,853
+307,208
| +13% | +$55.7M | 0.21% | 105 |
|
|
2021
Q2 | $494M | Buy |
2,451,645
+382,126
| +18% | +$77M | 0.21% | 97 |
|
|
2021
Q1 | $445M | Sell |
2,069,519
-17,648
| -0.8% | -$3.79M | 0.2% | 105 |
|
|
2020
Q4 | $493M | Buy |
2,087,167
+473,124
| +29% | +$112M | 0.23% | 89 |
|
|
2020
Q3 | $439M | Buy |
1,614,043
+60,494
| +4% | +$16.5M | 0.24% | 85 |
|
|
2020
Q2 | $451M | Buy |
1,553,549
+150,223
| +11% | +$43.6M | 0.28% | 72 |
|
|
2020
Q1 | $334M | Buy |
1,403,326
+46,491
| +3% | +$11.1M | 0.24% | 83 |
|
|
2019
Q4 | $297M | Sell |
1,356,835
-28,058
| -2% | -$6.14M | 0.18% | 108 |
|
|
2019
Q3 | $235M | Sell |
1,384,893
-8,710
| -0.6% | -$1.48M | 0.16% | 135 |
|
|
2019
Q2 | $256M | Buy |
1,393,603
+36,663
| +3% | +$6.72M | 0.18% | 109 |
|
|
2019
Q1 | $250M | Sell |
1,356,940
-2,539
| -0.2% | -$467K | 0.19% | 109 |
|
|
2018
Q4 | $225M | Buy |
1,359,479
+36,635
| +3% | +$6.07M | 0.19% | 105 |
|
|
2018
Q3 | $255M | Sell |
1,322,844
-36,920
| -3% | -$7.12M | 0.19% | 108 |
|
|
2018
Q2 | $231M | Buy |
1,359,764
+128,779
| +10% | +$21.9M | 0.18% | 119 |
|
|
2018
Q1 | $201M | Sell |
1,230,985
-10,748
| -0.9% | -$1.75M | 0.16% | 142 |
|
|
2017
Q4 | $186M | Buy |
1,241,733
+123,996
| +11% | +$18.6M | 0.16% | 137 |
|
|
2017
Q3 | $170M | Sell |
1,117,737
-56,465
| -5% | -$8.58M | 0.15% | 141 |
|
|
2017
Q2 | $151M | Sell |
1,174,202
-192,562
| -14% | -$24.8M | 0.15% | 157 |
|
|
2017
Q1 | $149M | Sell |
1,366,764
-869,983
| -39% | -$95.1M | 0.15% | 149 |
|
|
2016
Q4 | $165M | Sell |
2,236,747
-538,588
| -19% | -$39.7M | 0.18% | 125 |
|
|
2016
Q3 | $242M | Sell |
2,775,335
-3,335
| -0.1% | -$291K | 0.26% | 82 |
|
|
2016
Q2 | $239M | Sell |
2,778,670
-175,045
| -6% | -$15.1M | 0.27% | 80 |
|
|
2016
Q1 | $235M | Buy |
2,953,715
+50,977
| +2% | +$4.05M | 0.27% | 80 |
|
|
2015
Q4 | $365M | Sell |
2,902,738
-209,851
| -7% | -$26.4M | 0.42% | 47 |
|
|
2015
Q3 | $324M | Sell |
3,112,589
-117,866
| -4% | -$12.3M | 0.36% | 61 |
|
|
2015
Q2 | $399M | Buy |
3,230,455
+464,790
| +17% | +$57.4M | 0.38% | 56 |
|
|
2015
Q1 | $326M | Buy |
2,765,665
+1,306,619
| +90% | +$154M | 0.31% | 69 |
|
|
2014
Q4 | $173M | Buy |
1,459,046
+114,514
| +9% | +$13.6M | 0.17% | 145 |
|
|
2014
Q3 | $151M | Buy |
1,344,532
+11,415
| +0.9% | +$1.28M | 0.15% | 156 |
|
|
2014
Q2 | $126M | Sell |
1,333,117
-37,135
| -3% | -$3.52M | 0.13% | 181 |
|
|
2014
Q1 | $96.9M | Buy |
1,370,252
+177,586
| +15% | +$12.6M | 0.1% | 229 |
|
|
2013
Q4 | $88.6M | Buy |
1,192,666
+44,075
| +4% | +$3.27M | 0.1% | 225 |
|
|
2013
Q3 | $87.1M | Buy |
1,148,591
+175,102
| +18% | +$13.3M | 0.11% | 216 |
|
|
2013
Q2 | $77.8M | Buy |
+973,489
| New | +$77.8M | 0.1% | 234 |
|